Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.45
+0.35 (4.93%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Addex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
6711436045
Upgrade
Market Cap Growth
-3.16%-34.64%-74.03%-28.14%34.18%-25.63%
Upgrade
Enterprise Value
22027407
Upgrade
Last Close Price
7.106.0512.60125.80268.00-
Upgrade
PS Ratio
8.103.757.1912.5013.7315.33
Upgrade
PB Ratio
0.435.402.112.333.641.70
Upgrade
P/TBV Ratio
0.605.402.112.333.641.70
Upgrade
EV/Sales Ratio
2.761.060.287.769.202.50
Upgrade
Debt / Equity Ratio
0.000.300.080.030.040.02
Upgrade
Asset Turnover
0.070.260.090.150.150.08
Upgrade
Quick Ratio
4.361.392.305.035.185.57
Upgrade
Current Ratio
4.591.462.385.315.385.70
Upgrade
Return on Equity (ROE)
-168.91%-348.48%-190.48%-97.35%-64.08%-45.64%
Upgrade
Return on Assets (ROA)
-75.64%-99.44%-83.22%-45.37%-28.76%-24.26%
Upgrade
Return on Capital (ROIC)
-90.07%-189.67%-113.00%-59.47%-37.10%-27.95%
Upgrade
Earnings Yield
112.60%-170.78%-200.32%-38.95%-24.15%-34.03%
Upgrade
FCF Yield
-119.00%-129.41%-158.28%-37.39%-22.99%-21.90%
Upgrade
Buyback Yield / Dilution
-42.00%-64.45%-32.43%-27.88%-0.96%-13.46%
Upgrade
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q